EFFICACY AND SAFETY OF DRUG-ELUTING BALLOONS (DEB) IN THE TREATMENT OF PATIENTS PRESENTED WITH ACUTE STEMI

MW JAN; SA KHAN; F  AKBAR; N KHAN; G RAHMAN; . NASRULLAH

doi:10.54112/bcsrj.v2023i1.467

Authors

MW JAN Department of Adult Cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan
SA KHAN Department of Adult Cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan
F AKBAR Department of Intervention Cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan
N KHAN Department of Adult Cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan
G RAHMAN Department of Intervention Cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan
. NASRULLAH Department of Intervention Cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.467

Keywords:

DEBs,, Acute STEMI, PercutaneCoronary Intervention (PCI), MACE, Troponin, Creatine Kinase-MB, Cardiovascular Intervention, Myocardial Reperfusion, Cardiac Biomarkers

Abstract

Drug-eluting balloons (DEB) have emerged as a promising strategy for coronary revascularization, offering the capability to deliver anti-proliferative medicines directly to coronary arteries. Nevertheless, the exploration of their role in the acute STEMI context is now underway. Objective: To assess the efficacy of DEB in mitigating major adverse cardiac events (MACE) among individuals diagnosed with Acute ST-segment elevation myocardial infarction (STEMI) at the Peshawar Institute of Cardiology. The present study employed various methodologies to investigate the research question. A prospective cohort study was undertaken during a period spanning from September 2022 to June 2023, encompassing a sample size of 100 eligible participants. The study gathered data on the baseline characteristics of the participants, as well as the details of the DEB intervention. Additionally, safety outcomes were assessed and recorded. The study included statistical analyses to evaluate alterations in troponin and CK-MB levels following DEB intervention. During the follow-up period, many patient outcomes were documented, including MACE, occurrences of bleeding episodes, and instances of restenosis. The study's findings demonstrated noteworthy decreases in troponin and CK-MB levels following the DEB intervention, suggesting effective restoration of blood flow to the heart muscle. The study observed a significant decrease in troponin levels, from an initial mean of 12.7 ng/mL (±4.6) to a final mean of 5.3 ng/mL (±2.1) (p < 0.001). Similarly, CK-MB levels showed a significant reduction, with an initial mean of 42.3 U/L (±12.8) decreasing to a final mean of 20.5 U/L (±8.3) (p < 0.001). Nevertheless, there was a notable rise in MACE rates after the DEB intervention, as 38% of the individuals observed encountered MACE throughout the follow-up period. The safety concerns encompass hemorrhagic episodes, occurring in 10% of cases, and restenosis observed in 14% of cases. In conclusion, DEB has shown effectiveness in attaining myocardial reperfusion. However, the observed rise in MACE rates and safety concerns emphasize the intricate nature of DEB utilization in cases of acute STEMI. Additional investigation is required to enhance the process of selecting patients and refining procedure approaches within this particular environment.

Downloads

Download data is not yet available.

References

Ayyub, J., Dabhi, K. N., Gohil, N. V., Tanveer, N., Hussein, S., Pingili, S., Makkena, V. K., Jaramillo, A. P., Awosusi, B. L., and Nath, T. S. (2023). Evaluation of the Safety and Efficacy of Conventional Transarterial Chemoembolization (cTACE) and Drug-Eluting Bead (DEB)-TACE in the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review. Cureus 15.

Garcia-Garcia, H. M., McFadden, E. P., von Birgelen, C., Rademaker-Havinga, T., Spitzer, E., Kleiman, N. S., Cohen, D. J., Kennedy, K. F., Camenzind, E., and Mauri, L. (2019). Impact of periprocedural myocardial biomarker elevation on mortality following elective percutaneous coronary intervention. JACC: Cardiovascular Interventions 12, 1954-1962.

Hirshon, J. M., Alson, R. L., Blunk, D., Brosnan, D. P., Epstein, S. K., Gardner, A. F., Lum, D. L., Moskovitz, J. B., Richardson, L. D., and Stankus, J. L. (2014). America's emergency care environment, a state-by-state report card: 2014 edition. Annals of emergency medicine 63, 100-243.

Indermuehle, A., Bahl, R., Lansky, A. J., Froehlich, G. M., Knapp, G., Timmis, A., and Meier, P. (2013). Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials. Heart 99, 327-333.

Lopes, R. D., Heizer, G., Aronson, R., Vora, A. N., Massaro, T., Mehran, R., Goodman, S. G., Windecker, S., Darius, H., and Li, J. (2019). Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. New England Journal of Medicine 380, 1509-1524.

Martin, M., Perez-Alonso, A., and Asensio, J. (2013). Vascular complications and special problems in vascular trauma. European Journal of Trauma and Emergency Surgery 39, 569-589.

Mehta, S., Granger, C., Grines, C. L., Jacobs, A., Henry, T. D., Rokos, I., Lansky, A., Baumbach, A., Botelho, R., and Ferre, A. (2018). Confronting system barriers for ST-elevation MI in low and middle income countries with a focus on India. Indian heart journal 70, 185-190.

Murnaghan, K., Bishop, H., Sandila, N., Kidwai, B., Quraishi, A. U. R., Kells, C., Beydoun, H., and Elkhateeb, O. (2022). Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study. Journal of Interventional Cardiology 2022.

Ozaki, Y., Katagiri, Y., Onuma, Y., Amano, T., Muramatsu, T., Kozuma, K., Otsuji, S., Ueno, T., Shiode, N., and Kawai, K. (2018). EXPERT CONSENSUS DOCUMENT: CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018. Cardiovascular intervention and therapeutics/Japanese Association of Cardiovascular Intervention and Therapeutics [編] 33, 178-203.

Ramakrishna, C., Dave, B. A., Kothavade, P. S., Joshi, K. J., and Thakkar, A. S. (2017). Basic concepts and clinical outcomes of drug-eluting balloons for treatment of coronary artery disease: an overview. Journal of Clinical and Diagnostic Research: JCDR 11, OE01.

Spaulding, C., Krackhardt, F., Bogaerts, K., Urban, P., Meis, S., Morice, M.-C., and Eccleshall, S. (2023). Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial. American Heart Journal 258, 77-84.

Stătescu, C., Anghel, L., Tudurachi, B.-S., Leonte, A., Benchea, L.-C., and Sascău, R.-A. (2022). From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction. International Journal of Molecular Sciences 23, 9168.

Subban, V., Raffel, O. C., Vasu, N., Victor, S. M., and Sankardas, M. A. (2018). Intravascular ultrasound and optical coherence tomography for the assessment of coronary artery disease and percutaneous coronary intervention optimization: Specific lesion subsets. Indian Heart Journal Interventions 1, 95.

Tan, Q., Wang, Q., Yang, H., Jing, Z., and Ming, C. (2021). Clinical outcomes of drug-eluting balloon for treatment of small coronary artery in patients with acute myocardial infarction. Internal and Emergency Medicine 16, 913-918.

Wei, L., Dong, J.-X., Jin, L.-X., He, J., Zhao, C.-X., Kong, L.-C., An, D.-A.-L., Ding, S., Yang, F., and Yang, Y.-N. (2023). Peak early diastolic strain rate improves prediction of adverse cardiovascular outcomes in patients with ST-elevation myocardial infarction. La radiologia medica, 1-14.

Yang, Y.-X., Zhang, H.-P., Li, C., Fu, Y., He, K.-Z., Liu, X.-M., Wang, H.-J., Xia, K., Xu, L., and Zhong, J.-C. (2023). Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction. European Journal of Medical Research 28, 334.